Stay updated on Magrolimab Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Magrolimab Combo in AML Clinical Trial page.

Latest updates to the Magrolimab Combo in AML Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check29 days agoChange DetectedDocument revision updated from v3.4.1 to v3.4.2 for study-related materials.SummaryDifference0.0%

- Check36 days agoChange DetectedPage revision tag updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check44 days agoChange DetectedUI text updates include a 'Show glossary' label and capitalization adjustments for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a new page revision tag 'Revision: v3.4.0' replacing the previous 'v3.3.4'.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check79 days agoChange DetectedLocations section updated with numerous state and national sites and a new revision tag v3.3.3. Some locations were removed or reorganized.SummaryDifference1%

Stay in the know with updates to Magrolimab Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab Combo in AML Clinical Trial page.